Author
Listed:
- Raoul Kenfack-Momo
- Marceline Djuidje Ngounoue
- Sebastien Kenmoe
- Guy Roussel Takuissu
- Jean Thierry Ebogo-Belobo
- Cyprien Kengne-Ndé
- Donatien Serge Mbaga
- Elisabeth Zeuko’o Menkem
- Robertine Lontuo Fogang
- Serges Tchatchouang
- Juliette Laure Ndzie Ondigui
- Ginette Irma Kame-Ngasse
- Josiane Kenfack-Zanguim
- Jeannette Nina Magoudjou-Pekam
- Arnol Bowo-Ngandji
- Maimouna Mahamat
- Seraphine Nkie Esemu
- Lucy Ndip
- Richard Njouom
Abstract
Dialysis is a replacement therapy for patients with End-Stage Renal Disease (ESRD). Patients on dialysis are at high risk of acquiring hepatitis C virus (HCV), which has become a leading cause of morbidity and mortality in this population. There is a wide range of prevalence of HCV in dialysis populations around the world. It is still unknown how prevalent HCV infection is among worldwide dialysis patients (including those undergoing hemodialysis and peritoneal dialysis). A review was conducted to estimate the global epidemiology of hepatitis C in dialysis patients. We searched PubMed, Excerpta Medica Database (Embase), Global Index Medicus and Web of Science until October 2022. A manual search of references from relevant articles was also conducted. Heterogeneity was evaluated by the χ2 test on Cochrane’s Q statistic, and the sources of heterogeneity were investigated using subgroup analysis. In order to assess publication bias, funnel plots and Egger tests were conducted, and pooled HCV prevalence estimates were generated using a DerSimonian and Laird meta-analysis model. The study is registered with PROSPERO under CRD42022237789. We included 634 papers involving 392160 participants. The overall HCV case fatality rate was 38.7% (95% CI = 28.9–49). The global prevalence of HCV infection in dialysis population group were 24.3% [95% CI = 22.6–25.9]. As indicated by UNSD region, country, dialysis type, and HCV diagnostic targeted; Eastern Europe had the highest prevalence of 48.6% [95% CI = 35.2–62], Indonesia had 63.6% [95% CI = 42.9–82], hemodialysis patients had 25.5% [95% CI = 23.8–27.3], and anti-HCV were detected in 24.5% [95% CI = 22.8–26.2]. Dialysis patients, particularly those on hemodialysis, have a high prevalence and case fatality rate of HCV infection. Hemodialysis units need to implement strict infection control measures.
Suggested Citation
Raoul Kenfack-Momo & Marceline Djuidje Ngounoue & Sebastien Kenmoe & Guy Roussel Takuissu & Jean Thierry Ebogo-Belobo & Cyprien Kengne-Ndé & Donatien Serge Mbaga & Elisabeth Zeuko’o Menkem & Robertine, 2024.
"Global epidemiology of hepatitis C virus in dialysis patients: A systematic review and meta-analysis,"
PLOS ONE, Public Library of Science, vol. 19(2), pages 1-15, February.
Handle:
RePEc:plo:pone00:0284169
DOI: 10.1371/journal.pone.0284169
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0284169. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.